Solid Organ Transplantation in the Era of COVID-19

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes the coronavirus disease 2019 (COVID-19), posing a new challenge to the medical care of solid organ transplant (SOT) recipients. Due to the relatively small number of studies in SOT recipients suffering from COVID-19, the natural cou...

全面介紹

Saved in:
書目詳細資料
格式: Online
語言:英语
出版: MDPI - Multidisciplinary Digital Publishing Institute 2023
主題:
在線閱讀:ONIX_20230405_9783036565132_15
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!
_version_ 1869518464613351424
collection Directory of Open Access Books
description Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes the coronavirus disease 2019 (COVID-19), posing a new challenge to the medical care of solid organ transplant (SOT) recipients. Due to the relatively small number of studies in SOT recipients suffering from COVID-19, the natural course of the SARS-CoV-2 infection, optimal treatment strategies including modification of immunosuppressive therapy and the prognosis in COVID-19 in these patients is incompletely understood. The current Special Issue aimed to fill some of the knowledge gaps and highlight some recent advances in the management of SOT patients during the pandemic. The call for manuscripts had been addressed to healthcare professionals involved in SOT patient care. We welcomed comprehensive reviews, original studies, interesting case series or case reports and commentaries relating to this topic.
format Online
id doab-20.500.12854ir-98736
institution Directory of Open Access Books
language eng
publishDate 2023
publishDateRange 2023
publishDateSort 2023
publisher MDPI - Multidisciplinary Digital Publishing Institute
publisherStr MDPI - Multidisciplinary Digital Publishing Institute
record_format ojs
spelling doab-20.500.12854ir-987362024-03-30T23:22:19Z Solid Organ Transplantation in the Era of COVID-19 Schuurmans, Macé M. Hage, René SARS-CoV-2 coronavirus immunosuppression tacrolimus corticosteroids mycophenolate mofetil hyperinflammation cytokine storm pandemic transplantation Lung Transplantation COVID-19 Coronavirus norovirus treatment hypothesis cytokine storm syndrome FK506 cyclosporine myocarditis pediatric heart transplantation viral infection dexamethasone remdesivir hemodialysis transplant kidney PCR infection transplant recipients inflammation survival n/a solid-organ transplant unvaccinated lung transplantation fibrosis phenotype hypothesis lung transplant recipients immunocompromised breakthrough infections chronic lung allograft dysfunction community-acquired respiratory viral infection CLAD hypothesis thema EDItEUR::M Medicine and Nursing Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes the coronavirus disease 2019 (COVID-19), posing a new challenge to the medical care of solid organ transplant (SOT) recipients. Due to the relatively small number of studies in SOT recipients suffering from COVID-19, the natural course of the SARS-CoV-2 infection, optimal treatment strategies including modification of immunosuppressive therapy and the prognosis in COVID-19 in these patients is incompletely understood. The current Special Issue aimed to fill some of the knowledge gaps and highlight some recent advances in the management of SOT patients during the pandemic. The call for manuscripts had been addressed to healthcare professionals involved in SOT patient care. We welcomed comprehensive reviews, original studies, interesting case series or case reports and commentaries relating to this topic. 2023-04-05T12:48:28Z 2023-04-05T12:48:28Z 2023 book ONIX_20230405_9783036565132_15 9783036565132 9783036565149 https://directory.doabooks.org/handle/20.500.12854/98736 eng application/octet-stream Attribution 4.0 International https://mdpi.com/books/pdfview/book/6743 https://mdpi.com/books/pdfview/book/6743 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-0365-6514-9 10.3390/books978-3-0365-6514-9 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783036565132 9783036565149 128 Basel open access
spellingShingle SARS-CoV-2
coronavirus
immunosuppression
tacrolimus
corticosteroids
mycophenolate mofetil
hyperinflammation
cytokine storm
pandemic
transplantation
Lung Transplantation
COVID-19
Coronavirus
norovirus
treatment
hypothesis
cytokine storm syndrome
FK506
cyclosporine
myocarditis
pediatric heart transplantation
viral infection
dexamethasone
remdesivir
hemodialysis
transplant
kidney
PCR
infection
transplant recipients
inflammation
survival
n/a
solid-organ transplant
unvaccinated
lung transplantation
fibrosis
phenotype hypothesis
lung transplant recipients
immunocompromised
breakthrough infections
chronic lung allograft dysfunction
community-acquired respiratory viral infection
CLAD hypothesis
thema EDItEUR::M Medicine and Nursing
Solid Organ Transplantation in the Era of COVID-19
title Solid Organ Transplantation in the Era of COVID-19
title_full Solid Organ Transplantation in the Era of COVID-19
title_fullStr Solid Organ Transplantation in the Era of COVID-19
title_full_unstemmed Solid Organ Transplantation in the Era of COVID-19
title_short Solid Organ Transplantation in the Era of COVID-19
title_sort solid organ transplantation in the era of covid 19
topic SARS-CoV-2
coronavirus
immunosuppression
tacrolimus
corticosteroids
mycophenolate mofetil
hyperinflammation
cytokine storm
pandemic
transplantation
Lung Transplantation
COVID-19
Coronavirus
norovirus
treatment
hypothesis
cytokine storm syndrome
FK506
cyclosporine
myocarditis
pediatric heart transplantation
viral infection
dexamethasone
remdesivir
hemodialysis
transplant
kidney
PCR
infection
transplant recipients
inflammation
survival
n/a
solid-organ transplant
unvaccinated
lung transplantation
fibrosis
phenotype hypothesis
lung transplant recipients
immunocompromised
breakthrough infections
chronic lung allograft dysfunction
community-acquired respiratory viral infection
CLAD hypothesis
thema EDItEUR::M Medicine and Nursing
topic_facet SARS-CoV-2
coronavirus
immunosuppression
tacrolimus
corticosteroids
mycophenolate mofetil
hyperinflammation
cytokine storm
pandemic
transplantation
Lung Transplantation
COVID-19
Coronavirus
norovirus
treatment
hypothesis
cytokine storm syndrome
FK506
cyclosporine
myocarditis
pediatric heart transplantation
viral infection
dexamethasone
remdesivir
hemodialysis
transplant
kidney
PCR
infection
transplant recipients
inflammation
survival
n/a
solid-organ transplant
unvaccinated
lung transplantation
fibrosis
phenotype hypothesis
lung transplant recipients
immunocompromised
breakthrough infections
chronic lung allograft dysfunction
community-acquired respiratory viral infection
CLAD hypothesis
thema EDItEUR::M Medicine and Nursing
url ONIX_20230405_9783036565132_15